Only 30% of individuals with neuroendocrine tumors rank living longer as their single top priority in treating their cancer, according to a study conducted by researchers at City of Hope.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.